Suspended

Can Electroconvulsive Therapy Alter Retinal Nerve Fiber Layer Thickness of Patients With Depression

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Behavior

+ Behavioral Symptoms

+ Depression

From 18 to 65 Years
+8 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: January 2020
See protocol details

Summary

Principal SponsorMehmet Diyaddin Güleken
Study ContactMehmet D Güleken, MDMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: January 1, 2020

Actual date on which the first participant was enrolled.

Major depression (MD) is a mood disorder that is common in the society, has negative effects on emotion, thought and behavior, and leads to significant impairments in functionality. Electroconvulsive therapy (ECT) is a highly effective and reliable biological treatment method used in psychiatric diseases for a long time. The most common use in psychiatry is depression. Studies have shown that ECT causes a broadly distributed increase in brain gray matter volume (especially the temporal lobe) in MD patients. Optical coherence tomography (OCT) is a non-invasive medical imaging method that displays biological tissue layers by taking high resolution tomographic sections. Alterations in the thickness of the retinal nerve fiber layer (RNFL), which is a layer of the ganglion cell complex in the retina of the eye and consists of ganglion cell axons, occur due to axonal damage in the retinal nerve tissue. Since RNFL is in a similar form with the brain gray matter tissue, recently, neurological and psychiatric studies have been conducted to provide data regarding the neurodegeneration occurring in the brain tissue. In the study, it is aimed to assess the possible cortical volume changes of patients by measuring changes in the retinal layers due to ECT in patients with depression. In other words, considering that ECT causes an increase in brain volume, it is to observe whether this increase is reflected in the retinal nerve fiber layer thickness.

Official TitleCan Electroconvulsive Therapy Alter Retinal Nerve Fiber Layer Thickness of Patients With Depression
NCT04305132
Principal SponsorMehmet Diyaddin Güleken
Study ContactMehmet D Güleken, MDMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

50 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 65 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

BehaviorBehavioral SymptomsDepression

Criteria

3 inclusion criteria required to participate
Subject diagnosed as unipolar depression

Subject with depression to be treated with electroconvulsive therapy

Subject with depression having a Standardized Mini Mental Test score of >23

5 exclusion criteria prevent from participating
Having any major medical (i.e.: diabetes mellitus, myocardial infarction, etc.) disease

Any comorbid psychiatric condition (including alcohol / substance use)

Having any major neurological (i.e.: cerebrovascular disease, multiple sclerosis, etc.) disease

History of or having any ocular trauma, disease or surgery, any retinal disease, refraction defect

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

Sağlık Bilimleri Üniversitesi Gazi Yaşargil Tranining and Research Hospital

Diyarbakır, Turkey (Türkiye)Open Sağlık Bilimleri Üniversitesi Gazi Yaşargil Tranining and Research Hospital in Google Maps
SuspendedOne Study Center